# Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30

> **NCT04022291** · PHASE1 · COMPLETED · sponsor: **Biocon Limited** · enrollment: 78 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **BIOLOGICAL:** Humulin ®70/30
- **BIOLOGICAL:** Biocon Insulin 70/30

## Key facts

- **NCT ID:** NCT04022291
- **Lead sponsor:** Biocon Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-15
- **Primary completion:** 2020-01-20
- **Final completion:** 2020-01-27
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04022291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04022291, "Comparison of Pharmacokinetic (PK) and Pharmacodynamic(PD) of Biocon Insulin 70/30 and Humulin® 70/30". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04022291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*